Fixed-dose combination and therapeutic drug monitoring in tuberculosis: friend or foe?

Eur Respir J. 2016 Oct;48(4):1230-1233. doi: 10.1183/13993003.00833-2016. Epub 2016 Sep 1.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antitubercular Agents / therapeutic use*
  • Drug Combinations*
  • Drug Monitoring*
  • Humans
  • Isoniazid / therapeutic use
  • Pyrazinamide / therapeutic use
  • Rifampin / therapeutic use
  • Tuberculosis / drug therapy*

Substances

  • Antitubercular Agents
  • Drug Combinations
  • Pyrazinamide
  • Isoniazid
  • Rifampin